Osimertinib in Pulmonary Manifestations: Two Case Reports and Review of the Literature

od LU, HANNAH, DOWELL, JONATHAN
izdano v In Vivo (2020)

UKCAT and medical student selection in the UK – what has changed since 2006?

od Greatrix, Rachel, Dowell, Jonathan
izdano v BMC Med Educ (2020)

Small-Cell Lung Cancer: Translational Research Enroute to Therapeutic Advances

od Dowell, Jonathan, Minna, John D.
Izdano 2008

Modern management of malignant pleural mesothelioma

od Patel, Shivani C, Dowell, Jonathan E
izdano v Lung Cancer (Auckl) (2016)

Spotlight on bevacizumab and its potential in the treatment of malignant pleural mesothelioma: the evidence to date

od Levin, Pavel A, Dowell, Jonathan E
izdano v Onco Targets Ther (2017)

Beyond ‘health and safety’ – the challenges facing students asked to work outside of their comfort, qualification level or expertise on medical elective placement

od Wiskin, Connie, Dowell, Jonathan, Hale, Catherine
izdano v BMC Med Ethics (2018)

Widening access to UK medical education for under-represented socioeconomic groups: modelling the impact of the UKCAT in the 2009 cohort

od Tiffin, Paul A, Dowell, Jonathan S, McLachlan, John C
Izdano 2012

The UKCAT-12 study: educational attainment, aptitude test performance, demographic and socio-economic contextual factors as predictors of first year outcome in a cross-sectional co...

od McManus, I C, Dewberry, Chris, Nicholson, Sandra, Dowell, Jonathan S
Izdano 2013

Predictive validity of the UK clinical aptitude test in the final years of medical school: a prospective cohort study

od Husbands, Adrian, Mathieson, Alistair, Dowell, Jonathan, Cleland, Jennifer, MacKenzie, Rhoda
Izdano 2014

Cellular stress mechanisms of prenatal maternal stress: heat shock factors and oxidative stress

od Dowell, Jonathan, Elser, Benjamin A, Schroeder, Rachel E, Stevens, Hanna E
izdano v Neurosci Lett (2019)

Looking Beyond Surveillance, Epidemiology, and End Results: Patterns of Chemotherapy Administration for Advanced Non-small Cell Lung Cancer in a Contemporary, Diverse Population

od Rasco, Drew W., Yan, Jingsheng, Xie, Yang, Dowell, Jonathan E., Gerber, David E.
Izdano 2010

Upper Extremity Venous Thrombosis in Patients With Cancer With Peripherally Inserted Central Venous Catheters: A Retrospective Analysis of Risk Factors

od Ahn, Daniel H., Illum, Henrik Bo, Wang, David H., Sharma, Anant, Dowell, Jonathan E.
Izdano 2013

Construct-level predictive validity of educational attainment and intellectual aptitude tests in medical student selection: meta-regression of six UK longitudinal studies

od McManus, IC, Dewberry, Chris, Nicholson, Sandra, Dowell, Jonathan S, Woolf, Katherine, Potts, Henry WW
Izdano 2013

Predictors and impact of second-line chemotherapy for advanced non-small cell lung cancer in the United States: real-world considerations for maintenance therapy

od Gerber, David E., Rasco, Drew W., Le, Phat, Yan, Jingsheng, Dowell, Jonathan E., Xie, Yang
Izdano 2011

Consent Timing and Experience: Modifiable Factors That May Influence Interest in Clinical Research

od Gerber, David E., Rasco, Drew W., Skinner, Celette Sugg, Dowell, Jonathan E., Yan, Jingsheng, Sayne, Jennifer R., Xie, Yang
Izdano 2012

A phase 1 safety study of veliparib combined with cisplatin and etoposide in extensive stage small cell lung cancer: A trial of the ECOG-ACRIN Cancer Research Group (E2511)

od Owonikoko, Taofeek K., Dahlberg, Suzanne E., Khan, Saad A., Gerber, David E., Dowell, Jonathan, Moss, Rebecca A., Belani, Chandra P., Hann, Christine L., Aggarwal, Charu, Ramalingam, Suresh S.
izdano v Lung Cancer (2015)

Consolidative Radiotherapy for Limited Metastatic Non–Small-Cell Lung Cancer: A Phase 2 Randomized Clinical Trial

od Iyengar, Puneeth, Wardak, Zabi, Gerber, David E., Tumati, Vasu, Ahn, Chul, Hughes, Randall S., Dowell, Jonathan E., Cheedella, Naga, Nedzi, Lucien, Westover, Kenneth D., Pulipparacharuvil, Suprabha, Choy, Hak, Timmerman, Robert D.
izdano v JAMA Oncol (2017)

Randomized Phase II Trial of Erlotinib in Combination with High Dose-Celecoxib or Placebo in Patients with Advanced Non-small Cell Lung Cancer

od Reckamp, Karen L., Koczywas, Marianna, Cristea, Mihaela C., Dowell, Jonathan E., Wang, He-Jing, Gardner, Brian, Milne, Ginger L., Figlin, Robert A., Fishbein, Michael C., Elashoff, Robert M., Dubinett, Steven M.
izdano v Cancer (2015)

A randomized, phase 2 study of deoxyuridine triphosphatase inhibitor, TAS-114, in combination with S-1 versus S-1 alone in patients with advanced non-small-cell lung cancer

od Yamamoto, Nobuyuki, Hayashi, Hidetoshi, Planchard, David, Morán, Teresa, Gregorc, Vanesa, Dowell, Jonathan, Sakai, Hiroshi, Yoh, Kiyotaka, Nishio, Makoto, Cortot, Alexis B., Benhadji, Karim A., Soni, Nital, Huang, Jinhong, Makris, Lukas, Cedres, Susana
izdano v Invest New Drugs (2020)

Phase 1 study of romidepsin plus erlotinib in advanced non-small cell lung cancer

od Gerber, David E., Boothman, David A., Fattah, Farjana J, Dong, Ying, Zhu, Hong, Skelton, Rachel A., Priddy, Laurin L., Vo, Peggy, Dowell, Jonathan E., Sarode, Venetia, Leff, Richard, Meek, Claudia, Xie, Yang, Schiller, Joan H.
izdano v Lung Cancer (2015)